Tsla

Discussion in 'Stocks' started by nursebee, Aug 2, 2011.

  1. J Ski

    J Ski

    Stoned Investor,great writing in spite of negative tone this thread is heading in.
    Also been following a thread that is very interesting.
    "If you had a box that would make you money, a black or clear box, which would you choose?" It's under trade management forum.
    It's a bit of a dead thread and the OP may not be on this site anymore,
    as he became frustrated in replying to some idiotic posts.
    I been lazy thinking, and it has been painful to study the thread.
    I have not been a poetry fan in the past, but, something about
    reading and then writing prose is quite challenging, and it
    has got me into a very thoughtful mindset, for a change.
     
    #11     Aug 10, 2011
  2. Thanks jski- That's actually why i contributed here because things are rather dark right now. The question of the box is very interesting - my answer was immediately black but I don't why. perhaps you think you see what you see with a clear box and in a black box are indefinite possibilities and perhaps fear....

    TSLA is holding up fine here but it is $2 from a point that is real trouble. The better trade is EBAY which is amazingly holding onto $2 of yesterday's $3 gain.... I have orders at the hedge fund that holds my account to buy more EBAY & MRGE if the other black box kicks in today--- Although the world looks most dark now at down over 400 before noon my sense is we may have a gov sponsored spark and a short covering rally this afternoon and a generally better feeling about things tomorrow. What kind of spark? Yea I think there might be a secret committee that occasionally buys through the Fed desk. If there was ever a day to do it it's today.

    I did make a big purchase today and I'll do a separate thread on this name sometime after my vacation-- W.P. Carey. -- These guys had the great fortune of reporting yesterday and they zoomed but I have been following the name quite some time as I ready a new HIGH yield strategy for the end of summer/ fall. This is my first High yield play folks!!! A true sign of a bottom in tech! I just bought a nice lot at $35.60 or so The yield is 6.7%. symb (WPC).

    I think I have another great yield idea with a huge yield but I've sent the idea along for review so I don't want to jump the gun.

    Also I realized that TIP- that darn i share inflation protected thingymagiggy that I almost bought a dozen times, is at a 52 week high! Like Gold. interesting. It yields 3.9%.

    I'm thinking about discounted Muni's. The world has truly reached an upside down place.

    From the depths of your cave boys, at 2:22 pm initiate Project "BuyBuyBuy" and briefly regain the flat line, before closing this market only down 200.
    If there can be an only down 200.~stoney
     
    #12     Aug 10, 2011
  3. J Ski

    J Ski

    Things are dark.
    "May you live in interesting times" Confucious, seems a good quote around now.
    You have to read the entire thread, and if you are going on vacation then don't forget to take a laptop,or something like a tablet.
    Make sure it has an Intel chip in it :).
    My first buy of stock, INTC, in many years, and it's down from where I bought,
    $22.86.
    It is a very interesting thread.
    I've become quite obsessed with trying to force my brain to think in
    different ways. So that to me has been quite a tough thing to do.
    It's like give a man a fish, or teach a man to fish.
    I have asked my friends, the box question, and so far, and I don't have a wide circle of friends,everybody says the clear box.
     
    #13     Aug 10, 2011
  4. WOULD YOU BELIEVE UP A BUCK ON WPC ALREADY!!!!!

    oh and we have a large load too kiddies. That's why we put in the effort. To identify a high yield play that will also go up is a fine fine art let me tell you... stk after stk I find a hole in... a reason why there's a high dividend.... not this one. Real growth to boot.

    MRGE is looking fab IT'S UP!!!! Just bought more.... last time under $6, I'm sure.

    EBAY looking very good to me.... on the cusp of buying.

    Waiting on a high dividend SA telephone stk idea that's being sent to analyst

    TSLA doing nothing.

    Market rout shrunk to 270 on schedule. Now we need 200 more UPSIDE TO NEARLY break even. CAN WE DO IT? Unfortunately, I have to go buy 4 pounds of ground coffee for Fire Island vacation coming up and walk ole' Clyde.

    Clyde is an 11 year old Rhodesian Ridgeback and my best darn friend in the world.
    A trickster by nature and a food thief. The most handsome dog you ever saw I'm not kidding; everyone tells him so for 11 years.
    ~stoney
     
    #14     Aug 10, 2011
  5. J Ski

    J Ski

    Ridgebacks are awesome.
    Really a fan of American pits for the home.
    But other terriers in general are good too.
     
    #15     Aug 10, 2011
  6. The thing about Ridgebacks is they are VERY human like. The emotional factors run deep, from what I can tell Pitt Bulls have a bit of this also. It can be found in the eyes, the eyes so amber so deep so knowing and so hungry all the time.

    Well Folks Day 2 of the Bottom I guess.

    I really feel Tuesday & Wed were bottom like in the stocks frenetic plunge. Yesterday although the averages weighed down by energy and banks were down a lot, most stuff I'm looking out was sort of down 2% and on light volume. That can be a good sign.

    Today there is some great news in the medical world. Perhaps Bee Nurse will be interested. It appears after searching for so long and after myself have bought so many baby bios over the years looking for the magic bullet against cancer, perhaps, just perhaps we have been living with the solution all along-- AIDS. Yes using AIDS to fight cancer; sound amazing? Read This:

    NBC News
    updated 8/10/2011 7:20:14 PM ET 2011-08-10T23:20:14

    Doctors have treated only three leukemia patients, but the sensational results from a single shot could be one of the most significant advances in cancer research in decades. And it almost never happened.

    In the research published Wednesday, doctors at the University of Pennsylvania say the treatment made the most common type of leukemia completely disappear in two of the patients and reduced it by 70 percent in the third. In each of the patients as much as five pounds of cancerous tissue completely melted away in a few weeks, and a year later it is still gone.

    The results of the preliminary test “exceeded our wildest expectations,” says immunologist Dr. Carl June a member of the Abramson Cancer Center's research team.

    Dr. Edgar Engleman, a cancer immunologist at Stanford University School of Medicine who was not involved in the research calls the results “remarkable ... great stuff.”

    The Penn scientists targeted chroniclymphocytic leukemia (CLL), the most common type of the blood disease. It strikes some 15,000 people in the United States, mostly adults, and kills 4,300 every year. Chemotherapy and radiation can hold this form of leukemia at bay for years, but until now the only cure has been a bone marrow transplant. A bone marrow transplant requires a suitable match, works only about half the time, and often brings on severe, life-threatening side effects such as pain and infection.

    In the Penn experiment, the researchers removed certain types of white blood cells that the body uses to fight disease from the patients. Using a modified, harmless version of HIV, the virus that causes AIDS, they inserted a series of genes into the white blood cells. These were designed to make to cells target and kill the cancer cells. After growing a large batch of the genetically engineered white blood cells, the doctors injected them back into the patients.

    In similar past experimental treatments for several types of cancer the re-injected white cells killed a few cancer cells and then died out. But the Penn researchers inserted a gene that made the white blood cells multiply by a thousand fold inside the body. The result, as researcher June put it, is that the white blood cells became “serial killers” relentlessly tracking down and killing the cancer cells in the blood, bone marrow and lymph tissue.

    As the white cells killed the cancer cells, the patients experienced the fevers and aches and pains that one would expect when the body is fighting off an infection, but beyond that the side effects have been minimal.

    Doctors had told Bill Ludwig, one of the research volunteers, that he would die from his leukemia within weeks. Then he got the experimental treatment a year ago.

    With tears welling up, he told NBC, "I'm more closer to the people I love and I appreciate them more... I'm getting emotional... the grass is greener and flowers smell wonderful."

    The other two patients have chosen to remain anonymous but one who happens to be a scientist himself wrote, “I am still trying to grasp the enormity of what I am a part of -- and of what the results will mean to countless others with CLL or other forms of cancer. When I was a young scientist, like many I’m sure, I dreamed that I might make a discovery that would make a difference to mankind – I never imagined I would be part of the experiment.”

    So why has this remarkable treatment been tried so far on only three patients?

    Both the National Cancer Institute and several pharmaceutical companies declined to pay for the research. Neither applicants nor funders discuss the reasons an application is turned down. But good guesses are the general shortage of funds and the concept tried in this experiment was too novel and, thus, too risky for consideration.

    The researchers did manage to get a grant from the Alliance for Cancer Gene Therapy, a charity founded by Barbara and Edward Netter after their daughter-in-law died of cancer. The money was enough to finance the trials on the first three patients.

    With results for the three patients published Wednesday simultaneously in the New England Journal of Medicine and Science Translational Medicine, money for further studies -- not just in this one type of leukemia, but in other cancers -- will likely pour in from both the government and drug companies.

    Read the New England Journal of Medicine report
    NEJM: Redirecting T Cells

    It is important to emphasize that there still have been only three patients. Over the past century, many attempts to harness the body’s immune system to fight cancer have shown initial success and subsequent failure. So much research remains to be done to prove just how good this treatment is. But it should begin soon, with great vigor.

    >>>>>>>>>>>>

    WOW! Glory be!
    NO FUNDING FROM THE GOV.... it took a private family with a tragedy to sponsor this trial, the type of family Obama wants to raise taxes on... that money could of been sucked away into the government coffers to pay for a bunch of fat slobs with Diabetes and bullets for the war(s). Hummmmmmm.

    Bless these scientists!~stoney
     
    #16     Aug 11, 2011
  7. I had a dream last night guys. That Gold dropped hard.

    After listening to so many of these gold bulls explain how every possible economic situation leads to higher gold and how our whole system of money should really be gold and how some fund manager who is losing 20% has a shadow fund with his dollars invested denominated in Gold... Gold, gold gold.

    Then the Bloomberg guy yesterday sits on his oily stool and says maybe you can play the miners in a catch up play as they haven't moved with the price of gold... well there's a flip side to that rationalizing too... and that's a huge fall in in the price of Gold as that reverts to where the miners stock price's are sitting.

    When Gold goes down people will buy stocks. Someone besides me must know this. Create a rule about physically owning the gold SEC, some quirk.... some rapid change.... Perhaps Gold is but the last bubble left after tech/internet; bank and housing.....~ stoney
     
    #17     Aug 11, 2011
  8. SINGAPORE -- Asian central bankers will likely pause measures to contain high inflation until global market turmoil subsides, the chief economist at the Asian Development Bank said.

    A plunge in equity and commodities prices during the last week and growing concern the U.S. could fall back into recession will probably convince policymakers to halt interest rate hikes and currency appreciation, at least temporarily, the ADB's Changyong Rhee said Thursday in an interview with The Associated Press.

    "They will probably stop tightening for the next few weeks and months," Rhee said. "Once the market stabilizes, they will have to think about inflation again."

    Asian economies, excluding Japan, grew more in the first half than the ADB had forecast, but prices rose faster than expected as well, Rhee said. For the past year, Asian governments have sought to dampen quickening inflation with higher interest rates, stronger currencies and slower spending growth.

    Falling energy and food costs _ crude oil has slid 28 percent since May _ should help ease inflation pressures, Rhee said.

    The central banks of Indonesia and South Korea left their benchmark lending rates unchanged at policy meetings this week.

    The ADB expects the U.S. economy to grow this year. However, if there is a sharp drop in export demand from developed countries in the second half, the economies of South Korea, China and Taiwan would be hurt the most, while India and Indonesia would be less affected, Rhee said.

    "Asia is not yet decoupled from the West," he said. "Even though we are getting more independent, Asia is still dependent on exports to the U.S. and Europe."

    Earlier this year, the ADB forecast the gross domestic product of emerging Asia would expand 7.8 percent. The bank plans to announce updated forecasts next month.

    Rhee said the most troubling aspect of the current debt crisis is the lack of agreement among policymakers about how to solve it. Some economists argue more government spending would help prevent an economic slowdown while others say austerity measures that cut fiscal deficits would restore confidence.

    "Investors are worried about a lack of a coordinated effort among the major players," Rhee said. "There's no consensus of what we need to do."

    >>>>>>>>>>>
    Well that was clear enough = BUY POT today! (the stock)
    >>>>>>>>>>>
    here's a weird dividend play you wouldn't think of a bio--found it in a thread on Dividend stocks....

    Meridien Bioscience (VIVO)
    Meridien has publicly announced a policy of setting a payout ratio of between 75% and 85% of each fiscal year's expected net earnings, although it is hedged by language that the actual declaration and amount of dividends will be determined by the board of directors in its discretion based upon its evaluation of earnings, cash flow requirements and future business developments, including acquisitions.

    In each of the last four fiscal years, VIVO’s cash from operations has exceeded their dividends paid. Their depreciation & amortization has consistently been more than capex needs and in all but their last fiscal year (ended September, 2010) their free cash flow exceeded dividend payments—and that was only a $3mm deficit. They have very low capex and working capital needs.
    Much is dependent on VIVO’s illumigene test sales. If this important product is unable to grow as expected, future dividends could be in question.
    Meridien Bioscience is a 19-year dividend raiser, but its last increase was in February of 2010. A recent plunge in its price has brought its yield up to about 4.4%.

    >>>>>>>>>>>>>>>>>>
    I also have Located a car protection/ car location stk from Israel with 6.6% yield! ~stoney
     
    #18     Aug 11, 2011
  9. J Ski

    J Ski

    Good news, I still read some of the news.
    Thinking out of the box. on the cancer treatment.
    Wright brothers weren't scientifically trained, bicycle mechanics,
    high school educated.
    I'm wading through the thread "when is the obvious not so obvious".
    I figured the password out to the first pdf puzzle.
    It is about 243 posts long.
    I've been reading it for several days now, and I have to take breaks
    to read up on things I've forgotten.
    Logic, Aristotle, Greek mythology, price analysis, standard distributions.
    Interesting dream, gold, amazing metal isn't it?

    The old scientists wanted to turn lead into gold. Have to look at the periodic chart, I think they're close.
     
    #19     Aug 11, 2011
  10. Ok. EBAY behaving real nice! Up on all buys of the last few days which is tough to do.

    I'm close to getting back into IPGP- this is the strongest of the tech stocks that I follow... not chart strong-- just strong position, leading edge tech and ramping sales.
    Obviously I need some conviction that we can string a long a few days of up before flat lining to do this....

    POT gapped up a buck at the open and I was unable to get a good fill... watching.

    I think today is a good day to eat a lunch. Then

    RPM up 3.5% with a 4.8% yield, I believe this will be stock number two in my HIGH yield mini strategy that is unfolding here in real time.

    Afternoon ideas: RPM & IPGP & POT~stoney
     
    #20     Aug 11, 2011